Detalles de la búsqueda
1.
A case of hepatitis-associated aplastic anaemia following living-donor liver transplantation for fulminant hepatitis showing loss of heterozygosity in the 6p chromosome in the affected liver.
Br J Haematol
; 204(2): 623-627, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011365
2.
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
Br J Haematol
; 204(5): 2086-2096, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296352
3.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755516
4.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(6): 681-688, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
5.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 700-705, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
6.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 689-699, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
7.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
8.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
9.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
10.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
11.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
12.
A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan.
Br J Haematol
; 203(3): 468-476, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37654088
13.
Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma.
Transfus Apher Sci
; 62(3): 103649, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739175
14.
[Japanese patient preferences between ravulizumab and eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria].
Rinsho Ketsueki
; 64(1): 9-17, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36775313
15.
[Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
Rinsho Ketsueki
; 63(8): 899-905, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36058861
16.
[Late-onset refractory autoimmune hemolytic anemia following autologous hematologic recovery after allo-HSCT in aplastic anemia-PNH syndrome].
Rinsho Ketsueki
; 63(5): 347-352, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35662156
17.
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.
Genes Immun
; 22(1): 35-43, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33627833
18.
The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
Br J Haematol
; 195(5): 770-780, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476805
19.
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival.
Br J Haematol
; 195(2): 217-229, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318926
20.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol
; 192(1): 190-199, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152120